Asimov careers

Asimov is a mammalian synthetic biology company that spun out of MIT in 2017. We focus on advancing the design and manufacture of next-generation medicines, including biologics, gene therapy, and cell therapy. Our platform integrates genetic engineering and computer-aided design, reimagining how biotechnology products can be developed. We are currently partnered with several of the world's largest biopharma companies and we've raised over $200M in venture capital from Andreessen Horowitz, Canada Pension Plan Investments, Fidelity Investments, Pillar VC, and more.